Truveta has raised a total of $515 million in funding over multiple rounds, achieving unicorn status in January 2025. Its latest Series C round of $320 million, closed on January 13, 2025, was backed by Providence Health & Services and Trinity Health. Founded in 2020 and headquartered in Seattle, United States, Truveta provides a life sciences and healthcare IT platform that aggregates anonymized patient data to enable AI-driven medical research and improved clinical outcomes. The company continues to expand globally in life sciences tech and healthcare IT.